18F-flourodeoxy-glucose PET/computed tomography in brain tumors: Value to patient management and survival outcomes

Rick Wray, Lilja Solnes, Esther Mena, Avner Meoded, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

18F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.

Original languageEnglish (US)
Pages (from-to)423-430
Number of pages8
JournalPET Clinics
Volume10
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

glucose
Brain Neoplasms
brain
tumors
tomography
Tomography
Glucose
Survival
Glioma
central nervous system
prognosis
evaluation
grade
therapy
Lymphoma
Central Nervous System
Therapeutics

Keywords

  • Brain
  • Cancer
  • Central nervous system neoplasm
  • Patient management
  • PET
  • PET/computed tomography
  • Survival outcomes
  • Tumor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

18F-flourodeoxy-glucose PET/computed tomography in brain tumors : Value to patient management and survival outcomes. / Wray, Rick; Solnes, Lilja; Mena, Esther; Meoded, Avner; Subramaniam, Rathan M.

In: PET Clinics, Vol. 10, No. 3, 01.07.2015, p. 423-430.

Research output: Contribution to journalArticle

@article{0a92d51f6abe4bc8b09e93404af8a123,
title = "18F-flourodeoxy-glucose PET/computed tomography in brain tumors: Value to patient management and survival outcomes",
abstract = "18F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.",
keywords = "Brain, Cancer, Central nervous system neoplasm, Patient management, PET, PET/computed tomography, Survival outcomes, Tumor",
author = "Rick Wray and Lilja Solnes and Esther Mena and Avner Meoded and Subramaniam, {Rathan M.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.cpet.2015.03.011",
language = "English (US)",
volume = "10",
pages = "423--430",
journal = "PET Clinics",
issn = "1556-8598",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - 18F-flourodeoxy-glucose PET/computed tomography in brain tumors

T2 - Value to patient management and survival outcomes

AU - Wray, Rick

AU - Solnes, Lilja

AU - Mena, Esther

AU - Meoded, Avner

AU - Subramaniam, Rathan M.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - 18F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.

AB - 18F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.

KW - Brain

KW - Cancer

KW - Central nervous system neoplasm

KW - Patient management

KW - PET

KW - PET/computed tomography

KW - Survival outcomes

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84931828650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931828650&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2015.03.011

DO - 10.1016/j.cpet.2015.03.011

M3 - Article

C2 - 26099676

AN - SCOPUS:84931828650

VL - 10

SP - 423

EP - 430

JO - PET Clinics

JF - PET Clinics

SN - 1556-8598

IS - 3

ER -